Other, smaller trials in patients who already have Alzheimers point both ways, with Edison et al reporting better executive scores and less temporal and whole-brain atrophy on liraglutide, while Gejl (n=38, 6 mo follow-up) and Mullins (n=21, 1.5 yrs follow-up) were neutral to negative, which is exactly what you expect from studies that are short, and not powered to read a slow, insidious disease
If youd like to get started today, you can contact our team.
Ozempic (semaglutide) is an FDA-approved once-weekly glucagon-like peptide-1 (GLP-1) agonist used to control blood sugar levels in people with type 2 diabetes and reduce the risk of heart problems, like heart attacks
Built on science, its products have clinical backing for their impact on digestion and metabolic health, including weight loss and diabetes management
Like, I know I did it because